Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8474)
All Articles published online
|
Publishing Process of This Article
|
Sep 21, 2018 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ocker M. Biomarkers for hepatocellular carcinoma: What’s new on the horizon? World J Gastroenterol 2018; 24(35): 3974-3979 [PMID: 30254402 DOI: 10.3748/wjg.v24.i35.3974] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i35/3974.htm |
| Number | Citing Articles |
| 1 |
Muhammad Usman, Yasir Hameed. GNB1, a novel diagnostic and prognostic potential biomarker of head and neck and liver hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2022; 0(0): 0 doi: 10.4103/jcrt.jcrt_1901_20
|
| 2 |
Darmadi Darmadi, Riska Habriel Ruslie, Cennikon Pakpahan. Association between serum midkine levels and tumor size in Indonesian hepatocellular carcinoma patients: a cross-sectional study. Romanian Journal of Internal Medicine 2022; 60(4): 229 doi: 10.2478/rjim-2022-0014
|
| 3 |
Xiaofeng Chen, Wei Li, Xiaofeng Wu, Fengjiao Zhao, Deqiang Wang, Hao Wu, Yanhong Gu, Xiao Li, Xiaofeng Qian, Jun Hu, Changxian Li, Yongxiang Xia, Jianhua Rao, Xinzheng Dai, Qianwen Shao, Jie Tang, Xiangcheng Li, Yongqian Shu. Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.909035
|
| 4 |
Modibo Coulibaly, Adama Kondé, Djibril Traoré, Ousmane Bah, Valentin Sagara, Bakary Maiga. Assessment of alpha-fetoprotein clinical performances in the diagnosis of the hepatocellular carcinoma at Sominé DOLO hospital of Mopti. International Journal of Clinical Biochemistry and Research 2023; 10(2): 163 doi: 10.18231/j.ijcbr.2023.028
|
| 5 |
Mohamed Eissa, Selmy Awad, Somaya Barakat, Ahmed Saleh, Salah Rozaik. Serum Golgi protein 73 as a sensitive biomarker for early detection of hepatocellular carcinoma among Egyptian patients with hepatitis C virus-related cirrhosis. Medical Journal Armed Forces India 2021; 77(3): 331 doi: 10.1016/j.mjafi.2020.11.013
|
| 6 |
Walid S. Ayoub, Justin Steggerda, Ju Dong Yang, Alexander Kuo, Vinay Sundaram, Shelly C. Lu. Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers. Therapeutic Advances in Medical Oncology 2019; 11 doi: 10.1177/1758835919869120
|
| 7 |
Chengzhi Gao, Guangming Zhou, Min Cheng, Lan Feng, Pengbo Cao, Gangqiao Zhou. Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.956094
|
| 8 |
AshrafA Dawood, NaglaaM Ghanayem, AhmedK Khamis, HasnaaM Shibl, MonaS Habieb. The Value of serum Golgi protein 73 as a biomarker for hepatocellular carcinoma. Menoufia Medical Journal 2022; 35(2): 559 doi: 10.4103/mmj.mmj_225_21
|
| 9 |
Omaima Mohamed Ali, Hussein Ahmed El Amin, Yousry Lotfy Sharkawy, Adnan Ahmed Mohamed Ali, Emad Farah Mohammed Kholef, Wael Abd Elgwad Elsewify. <p>Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma</p>. International Journal of General Medicine 2020; : 193 doi: 10.2147/IJGM.S253622
|
| 10 |
D.-w. Sun, L. An, H.-y. Huang, X.-d. Sun, G.-y. Lv. Establishing peripheral PD-L1 as a prognostic marker in hepatocellular carcinoma patients: how long will it come true?. Clinical and Translational Oncology 2021; 23(1): 82 doi: 10.1007/s12094-020-02390-y
|
| 11 |
Payal Deepak, Rajinikanth Siddalingam, Praveen Kumar, Sneha Anand, Sunita Thakur, Balasubramaniam Jagdish, Shweta Jaiswal. Gene based nanocarrier delivery for the treatment of hepatocellular carcinoma. Journal of Drug Delivery Science and Technology 2020; 59: 101837 doi: 10.1016/j.jddst.2020.101837
|
| 12 |
Mehrdad Ameri, Haniye Salimi, Sedigheh Eskandari, Navid Nezafat. Identification of potential biomarkers in hepatocellular carcinoma: A network-based approach. Informatics in Medicine Unlocked 2022; 28: 100864 doi: 10.1016/j.imu.2022.100864
|
| 13 |
Jiapan Gu, Ziyuan Zhao, Zeng Zeng, Yuzhe Wang, Zhengyiren Qiu, Bharadwaj Veeravalli, Brian Kim Poh Goh, Glenn Kunnath Bonney, Krishnakumar Madhavan, Chan Wan Ying, Lim Kheng Choon, Thng Choon Hua, Pierce K. H. Chow. Multi-Phase Cross-modal Learning for Noninvasive Gene Mutation Prediction in Hepatocellular Carcinoma. 2020 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2020; : 5814 doi: 10.1109/EMBC44109.2020.9176677
|
| 14 |
Xuemin Pan, Ping Lin, Fangyoumin Feng, Jia Li, Yuan-Yuan Li, Wentao Dai, Bo Hu, Xin-Rong Yang, Jia Fan, Hong Li, Yixue Li. Comparison of immune profiles between hepatocellular carcinoma subtypes. Biophysics Reports 2020; 6(1): 19 doi: 10.1007/s41048-019-00102-w
|
| 15 |
Yotsawat Pomyen, Anuradha Budhu, Jittiporn Chaisaingmongkol, Marshonna Forgues, Hien Dang, Mathuros Ruchirawat, Chulabhorn Mahidol, Xin Wei Wang, Benjarath Pupacdi, Siritida Rabibhadana, Kannikar Phonphutkul, Nirush Lertprasertsuke, Anon Chotirosniramit, Chirayu U. Auewarakul, Teerapat Ungtrakul, Vajarabhongsa Budhisawasdi, Chawalit Pairojkul, Suleeporn Sangrajang, Curtis C. Harris, Christopher A. Loffredo, Robert Wiltrout. Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91560-1
|
| 16 |
Daniel Neureiter, Sebastian Stintzing, Tobias Kiesslich, Matthias Ocker. Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets. World Journal of Gastroenterology 2019; 25(25): 3136-3150 doi: 10.3748/wjg.v25.i25.3136
|
| 17 |
Nikolaos K. Gatselis, Kalliopi Zachou, George Giannoulis, Stella Gabeta, Gary L. Norman, George N. Dalekos. Serum Cartilage Oligomeric Matrix Protein and Golgi Protein-73: New Diagnostic and Predictive Tools for Liver Fibrosis and Hepatocellular Cancer?. Cancers 2021; 13(14): 3510 doi: 10.3390/cancers13143510
|
| 18 |
M. Ahmad, Y. Hameed, M. Khan, M Usman, A. Rehman, U. Abid, R. Asif, H. Ahmed, M. S. Hussain, J. U. Rehman, H. M. Asif, R. Arshad, M. Atif, A. Hadi, U. Sarfraz, U. Khurshid. Up-regulation of GINS1 highlighted a good diagnostic and prognostic potential of survival in three different subtypes of human cancer. Brazilian Journal of Biology 2024; 84 doi: 10.1590/1519-6984.250575
|
| 19 |
Harpreet Kaur, Sherry Bhalla, Dilraj Kaur, Gajendra PS Raghava. CancerLivER: a database of liver cancer gene expression resources and biomarkers. Database 2020; 2020 doi: 10.1093/database/baaa012
|
| 20 |
Zhenluo Jiang, Lili Shen, Shuwei Wang, Shengdong Wu, Yaoren Hu, Junming Guo, Liyun Fu. Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma. Cancer Medicine 2019; 8(17): 7278 doi: 10.1002/cam4.2584
|
| 21 |
Ting Song, Li Li, Shaobo Wu, Yan Liu, Caiping Guo, Wen Wang, Lili Dai, Tong Zhang, Hao Wu, Bin Su. Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.583714
|
| 22 |
Mary Wong, Jong T Kim, Brian Cox, Brent K Larson, Stacey Kim, Kevin M Waters, Eric Vail, Maha Guindi. Evaluation of tumor mutational burden in small early hepatocellular carcinoma and progressed hepatocellular carcinoma. Hepatic Oncology 2021; 8(4) doi: 10.2217/hep-2020-0034
|
| 23 |
Pelin BALÇIK ERÇİN. Integrative Analysis of SIX1 and Cancer Stem Cell Markers in Hepatocellular Carcinoma. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 2020; 7(3): 325 doi: 10.34087/cbusbed.689797
|
| 24 |
Chun-Ying Yan, Zuo-Jun Fu, Gui-Sheng Liu, Jiang Li, Chen-Xi Sun. Value of heat shock protein 90 combined with alpha-fetoprotein in early diagnosis of hepatocellular carcinoma. World Chinese Journal of Digestology 2021; 29(21): 1215 doi: 10.11569/wcjd.v29.i21.1215
|
| 25 |
Weiran Liao, Zhitian Shi, Haoren Tang, Tiangen Wu, Cheng Zhang, Yutao He, Renchao Zou, Lin Wang, Zhiqian Zhang. Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine Development. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/6851026
|
| 26 |
Shaoming Song, Mingzhen Bai, Xiaofei Li, Shiyi Gong, Wenwen Yang, Caining Lei, Hongwei Tian, Moubo Si, Xiangyong Hao, Tiankang Guo. Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2022; 22(3): 361 doi: 10.1080/14737159.2022.2049248
|
| 27 |
Kumar Jayant, Nagy Habib, Kai W. Huang, Mauro Podda, Jane Warwick, Ramesh Arasaradnam. Immunological Basis of Genesis of Hepatocellular Carcinoma: Unique Challenges and Potential Opportunities through Immunomodulation. Vaccines 2020; 8(2): 247 doi: 10.3390/vaccines8020247
|
| 28 |
Beatrice Cavalluzzo, Angela Mauriello, Concetta Ragone, Carmen Manolio, Maria Lina Tornesello, Franco M. Buonaguro, Siri Amanda Tvingsholm, Sine Reker Hadrup, Maria Tagliamonte, Luigi Buonaguro. Novel Molecular Targets for Hepatocellular Carcinoma. Cancers 2021; 14(1): 140 doi: 10.3390/cancers14010140
|